CompletedNot Applicable

COVID-19 in Polish Ice Swimmers.

Poland2,534 participantsStarted 2020-12-01

Plain-language summary

Ice swimming is an increasingly common phenomenon in Poland. It has been confirmed that it has a beneficial effect on health by increasing the natural non-specific immunity to infections. In the face of the current Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) pandemic causing Coronavirus Disease 2019 (COVID-19), researchers decided to use a survey to check the incidence of COVID-19 among Polish ice swimmers, as well as recent ailments. Then, the researchers will compare the obtained results with epidemiological data for Poland.Researchers will also investigate the relationship between susceptibility to SARS-CoV-2 infection and the blood group and Rh factor among ice swimmers.

Who can participate

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * ice swimmers Exclusion Criteria: * not active ice swimmers

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Assessment of the incidence of COVID-19 among ice swimmers compared to the general population.

Timeframe: 47 days.

Assessment of the frequency of asymptomatic SARS-CoV-2 infection among ice swimmers compared to the general population.

Timeframe: 47 days.

Assessment of the frequency of occurrence of particular symptoms of SARS-CoV-2 infection among ice swimmers compared to the general population.

Timeframe: 47 days.

Assessment of the frequency of COVID-19 treatment in an outpatient, inpatient and intensive care unit among ice swimmers compared to the general population.

Timeframe: 47 days.

Assessment of the impact of parameters and ice swimming strategies on the likelihood of developing COVID-19, the occurrence of individual symptoms of the disease and the severity of its course.

Timeframe: 47 days.

Assessment of the influence of blood group on susceptibility to SARS-CoV-2 infection among ice swimmers.

Timeframe: 47 days.

Trial details

NCT IDNCT04817280

SponsorWroclaw Medical University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-01-17

View on ClinicalTrials.gov More Covid19 trials

Plain-language summary

What they're measuring

Assessment of the incidence of COVID-19 among ice swimmers compared to the general population.

Timeframe: 47 days.

Assessment of the frequency of asymptomatic SARS-CoV-2 infection among ice swimmers compared to the general population.

Timeframe: 47 days.

Assessment of the frequency of occurrence of particular symptoms of SARS-CoV-2 infection among ice swimmers compared to the general population.

Timeframe: 47 days.

Assessment of the frequency of COVID-19 treatment in an outpatient, inpatient and intensive care unit among ice swimmers compared to the general population.

Timeframe: 47 days.

Assessment of the impact of parameters and ice swimming strategies on the likelihood of developing COVID-19, the occurrence of individual symptoms of the disease and the severity of its course.

Timeframe: 47 days.

Assessment of the influence of blood group on susceptibility to SARS-CoV-2 infection among ice swimmers.

Timeframe: 47 days.